All

Aug 12 2021

A Randomized, Open Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study)

McGowan IM, Chawki S, Hendrix CW, Anton PA, Marzinke MA, Brand RM, Engstrom JC, Rohan LC, Abebe KZ, Richardson-Harman N, Siegel A, Rineheart A, Steytler J, Stall R, Spiegel H, Chen B, Achilles SL,... More »

Jul 14 2021

Silicone elastomer formulations for improved performance of a multipurpose vaginal ring releasing dapivirine and levonorgestrel

Bashi YHD, Murphy DJ, McCoy CF, Boyd P, Brown L, Kihara M, Martin F, McMullen N, Kleinbeck K, Dangi B, Spence P, Hansraj B, Devlin B, Malcolm RK. Int J Pharm X. 2021 Jul; 3:100091. doi.org/10.1016/j.... More »

Jun 12 2021

Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States

Liu AY, Islas CD, Gundacker H, Neradilek B, Hoesley C, van der Straten A, Hendrix CW, Beamer M, Jacobson CE, McClure T, Harrell T, Bunge K, Devlin B, Nuttall J, Spence P, Steytler J, Piper JM,... More »

May 1 2021

Use of simulated vaginal and menstrual fluids to model in vivo discolouration of silicone elastomer vaginal rings

McCoy CF, Spence P, Bashi YHD, Murphy DJ, Boyd P, Dangi B, Derrick T, Devlin B, Kleinbeck K, Malcolm RK. Int J Pharm X. 2021 May 1;3:100081. eCollection 2021 Dec. More »

Feb 2 2021

Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study

Nel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A, Steytler J, van der Ryst E, Craig C, Louw C, Gwetu T, Mabude Z, Kotze P, Moraba R, Tempelman H, Gill K, Kusemererwa S, Bekker L-G,... More »

Pages